Fresenius | FRE - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Akzo Nobel EUR 68M 26M 2025-06
Alcon AG USD 52M 2M 2026-03
AstraZeneca USD 484M 181M 2025-12
BASF EUR 236M 15M 2025-12
Bayer EUR 675M 87M 2025-12
Beiersdorf EUR 7.5M 19.5M 2025-06
DaVita Healthcare Partners USD 17.5B 17.35B 2026-03
Demant DKK 398M 37M 2025-12
E.ON EUR 543M 7M 2025-12
Essilor EUR 168M 21M 2025-12
Fresenius EUR 81M 5M 2025-09
Fresenius Medical Care EUR 79M 6M 2026-03
Getinge SEK 133M 31M 2026-06
Givaudan CHF 58M 7M 2025-12
GlaxoSmithKline GBP 167M 21M 2026-03
GN Store Nord DKK 296M 42M 2025-12
GRIFOLS EUR 141.43M 61.28M 2025-06
Hikma Pharmaceutical USD 67M 47M 2025-12
Lonza CHF 84M 14M 2025-06
Merck EUR 104M 17M 2026-03
Novartis USD 343M 39M 2026-03
Philips EUR 83M 26M 2026-03
Roche Holding CHF 304M 7.5M 2025-06
RWE EUR 138M 214M 2025-12
Sanofi EUR 178M 203M 2026-03
Smith & Nephew USD 69M 1000K 2025-12